Cargando…

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?

Detalles Bibliográficos
Autores principales:	Rodor, Julie, Chen, Shiau-Haln, Baker, Andrew H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Cardiovascular Research Onlife
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325695/ https://www.ncbi.nlm.nih.gov/pubmed/37170759 http://dx.doi.org/10.1093/cvr/cvad075

Ejemplares similares

Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
por: Smeda, Marta, et al.
Publicado: (2020)

The selective PGI(2) receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats
por: Honda, Yohei, et al.
Publicado: (2020)

Limitations of the glycaemic index and the need for nuance when determining carbohydrate quality
por: Kanter, Mitch, et al.
Publicado: (2021)

Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
por: Guzik, Tomasz J
Publicado: (2017)

The curious case of dermal fibroblasts: cell identity loss may be a mechanism underlying cardiovascular aging
por: Badi, Ileana
Publicado: (2019)

Therapeutic gene editing, making a point
por: Smits, Anke M
Publicado: (2019)

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020)

ISCHEMIA: new questions from a landmark trial
por: Morrow, Andrew, et al.
Publicado: (2020)

The epitranscriptome: tools to study, manipulate, and exploit RNA modifications
por: Nossent, Anne Yaël
Publicado: (2019)

Up in the air: links between the environment and cardiovascular disease
por: Münzel, Thomas
Publicado: (2019)

Highlights of American Heart Association Scientific Sessions 2020: a virtual experience
por: Adão, Rui, et al.
Publicado: (2021)

Atrial fibrillation after cardiac surgery: to screen or not to screen?
por: Casadei, Barbara, et al.
Publicado: (2021)

Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2021)

New understanding of circulatory blood flow and arterial blood pressure mechanisms
por: Wolff, Christopher Bancroft, et al.
Publicado: (2022)

The post-pandemic legacy: the breakthrough of digital health and telemedicine
por: Bruining, Nico
Publicado: (2021)

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19
por: Pessoa-Amorim, Guilherme, et al.
Publicado: (2021)

Cardiovascular disease in transgender people: recent research and emerging evidence
por: Connelly, Paul J, et al.
Publicado: (2021)

Scientists on the Spot: The complex inheritance of cardiac disorders
por: Patel, Jyoti, et al.
Publicado: (2019)

What to expect from drug targeting factor XI?
por: Nagy, Magdolna, et al.
Publicado: (2022)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Sugen, hypoxia and the lung circulation
por: Voelkel, Norbert F., et al.
Publicado: (2021)

Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition
por: Yu, Min, et al.
Publicado: (2020)

Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives
por: Becker, Lisa M, et al.
Publicado: (2022)

Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension
por: Philip, Nicolas, et al.
Publicado: (2023)

Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
por: Al-Husseini, Aysar, et al.
Publicado: (2015)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
por: Alencar, Allan K. N., et al.
Publicado: (2018)

Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis
por: Huang, Qingyan, et al.
Publicado: (2021)

SOX Transcription Factors in Endothelial Differentiation and Endothelial-Mesenchymal Transitions
por: Yao, Yucheng, et al.
Publicado: (2019)

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis
por: Chen, Pei-Yu, et al.
Publicado: (2020)

Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
por: Alfaidi, Mabruka, et al.
Publicado: (2023)

Sugen–morphine model of pulmonary arterial hypertension
por: Agarwal, Stuti, et al.
Publicado: (2020)

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
por: Jun, Qiu, et al.
Publicado: (2022)

Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)

IL‐33/ST2 receptor‐dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice
por: Indralingam, Cynthia S., et al.
Publicado: (2022)

SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model
por: Peloquin, Grace L., et al.
Publicado: (2019)

MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents
por: Chen, Tianji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b22d7fl6ge9em46bj314mi7as9